93 7286 Pill - yellow oval, 18mm
Pill with imprint 93 7286 is Yellow, Oval and has been identified as Levetiracetam 500 mg. It is supplied by Teva Pharmaceuticals USA.
Levetiracetam is used in the treatment of Seizures; Epilepsy and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 7286
Levetiracetam
- Imprint
- 93 7286
- Strength
- 500 mg
- Color
- Yellow
- Size
- 18.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Pyrrolidine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00093-7286 (Discontinued)
- Inactive Ingredients
-
corn starch,
croscarmellose sodium,
hypromellose 2910 (6 mPa.s),
magnesium stearate,
polyethylene glycol 3350,
polyethylene glycol 4000,
povidone k30,
titanium dioxide,
FD&C Blue No. 2,
indigotindisulfonate sodium,
aluminum oxide,
FD&C Yellow No. 5,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "93 7286"
More about levetiracetam
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (429)
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: pyrrolidine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Levetiracetam oral/injection drug information
- Levetiracetam (Intravenous) (Advanced Reading)
- Levetiracetam (Oral) (Advanced Reading)
- Levetiracetam Extended-Release Tablets
- Levetiracetam Tablets
Other brands
Keppra, Keppra XR, Spritam, Elepsia XR, ... +2 more
Professional resources
- Levetiracetam monograph
- Levetiracetam (FDA)
- Levetiracetam Extended Release Tablets (FDA)
- Levetiracetam Injection (FDA)
- Levetiracetam Injection, Concentrate (FDA)
- Levetiracetam Solution (FDA)
Other brands
Keppra, Keppra XR, Spritam, Elepsia XR, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
